abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Investing Cash Flow
$10.17M
Quarterly · Period ending: · USD
HQL Investing Cash Flow
Latest reported$10.17Mperiod ending
Latest reported$10.17Mperiod ending
HQL Quarterly Cash from Investing ($250.00K → $10.17M)
Quarterly investing cash flow
High-resolution chart · PNG
HQL investing cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| 10,173,495 | |
| 20,825,540 | |
| 4,389,313 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 7,150,000 | |
| 7,150,000 | |
| -29,100,000 | |
| -29,100,000 | |
| 4,900,000 | |
| 4,900,000 | |
| 4,250,000 | |
| 4,250,000 | |
| 4,650,000 | |
| 4,650,000 | |
| 4,800,000 | |
| 4,800,000 | |
| 5,100,000 | |
| 5,100,000 | |
| 2,050,000 | |
| -50,000 | |
| 3,900,000 | |
| 3,900,000 | |
| 250,000 | |
| 250,000 |